CHEMOCENTRYX INC (CCXI) Stock Analyst Ratings
NASDAQ:CCXI - Nasdaq - US16383L1061 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 52% to CCXI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 53.04. This target is 2.02% above the current price.
CCXI was analyzed by 13 analysts. The buy percentage consensus is at 52. So analysts seem to be rather neutral about CCXI.
In the previous month the buy percentage consensus was at a similar level.
CCXI was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-08-10 | Stifel | Downgrade | Buy -> Hold |
| 2022-08-05 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-08-05 | Raymond James | Downgrade | Strong Buy -> Market Perform |
| 2022-08-05 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2022-08-05 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-05-06 | Raymond James | Maintains | Strong Buy |
| 2021-11-10 | Raymond James | Maintains | Strong Buy |
| 2021-10-11 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2021-10-11 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2021-10-11 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2021-10-08 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2021-07-07 | Stifel | Upgrade | Hold -> Buy |
| 2021-05-07 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2021-05-07 | Stifel | Downgrade | Buy -> Hold |
| 2021-05-07 | Raymond James | Downgrade | Strong Buy -> Outperform |
| 2021-05-07 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2021-05-07 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2021-05-07 | HC Wainwright & Co. | Maintains | Buy |
| 2021-03-02 | Stifel | Initiate | Buy |
| 2021-03-02 | Raymond James | Maintains | Strong Buy |